BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8564927)

  • 21. The expression of HSP70 and HSP90alpha in children with Wilms tumor.
    Yang Y; Niu ZB; Hou Y; Wang CL
    J Pediatr Surg; 2006 Jun; 41(6):1062-6. PubMed ID: 16769335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxicity induced by arsenic in Gallus Gallus: Regulation of oxidative stress and heat shock protein response.
    Zhao P; Guo Y; Zhang W; Chai H; Xing H; Xing M
    Chemosphere; 2017 Jan; 166():238-245. PubMed ID: 27697713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
    Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
    Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of DL-alpha-lipoic acid on methanol induced free radical changes, protein oxidative damages and hsp70 expression in folate deficient rat nervous tissue.
    Rajamani R; Muthuvel A; Manikandan S; Srikumar R; Sheeladevi R
    Chem Biol Interact; 2007 May; 167(3):161-7. PubMed ID: 17399694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic cytotoxic effect of quercetin and heat treatment in a lymphoid cell line (OZ) with low HSP70 expression.
    Fujita M; Nagai M; Murata M; Kawakami K; Irino S; Takahara J
    Leuk Res; 1997 Feb; 21(2):139-45. PubMed ID: 9112431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AC133 expression in egyptian children with acute leukemia: impact on treatment response and disease outcome.
    Elgendi HM; Mekawy MA; Abdel Wahab SE; Tawfik LM; Ismail EA; Adly AA
    J Pediatr Hematol Oncol; 2010 May; 32(4):286-93. PubMed ID: 20224439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol.
    Cui L; Gao C; Zhang RD; Jiao Y; Li WJ; Zhao XX; Liu SG; Yue ZX; Zheng HY; Deng GR; Wu MY; Li ZG; Jia HT
    Leuk Res; 2015 Feb; 39(2):115-23. PubMed ID: 25530566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia.
    Das DK; Engelman RM; Kimura Y
    Cardiovasc Res; 1993 Apr; 27(4):578-84. PubMed ID: 8324789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin-transferrin conjugate.
    Szwed M; Kania KD; Jozwiak Z
    Biochimie; 2014 Dec; 107 Pt B():358-66. PubMed ID: 25312849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients.
    Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
    Cancer Lett; 2007 Jul; 252(1):131-46. PubMed ID: 17276589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy.
    Kurahashi T; Miyake H; Hara I; Fujisawa M
    J Urol; 2007 Feb; 177(2):757-61. PubMed ID: 17222676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of expression of the genes for glutathione reductase, glutathione peroxidase, catalase and CuZn-superoxide dismutase in rat lens and liver.
    Shi S; Bekhor I
    Exp Eye Res; 1994 Aug; 59(2):171-7. PubMed ID: 7835406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
    Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of c-Jun expression induces antioxidant enzymes under serum deprivation.
    Kim YH; Takahashi M; Noguchi N; Suzuki E; Suzuki K; Taniguchi N; Niki E
    Arch Biochem Biophys; 2000 Feb; 374(2):339-46. PubMed ID: 10666316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
    J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.
    Te Kronnie G; Bicciato S; Franceschini L; Accordi B; Dellíorto MC; Rinaldi A; Pession A; Barisone E; Conter V; Locatelli F; Basso G
    Oncol Rep; 2006 Feb; 15(2):341-6. PubMed ID: 16391852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.